Loading compound...
Experimental protein-based compound
PX-478 is an experimental drug currently being studied for its potential use in treating lymphoma. It is in the early stages of research and is not yet approved for general use.
How it worksPX-478 is being researched for its ability to inhibit certain biological activities related to lymphoma.
Used for
Lymphoma
Conditions
Lymphoma
Class
ExperimentalExperimental protein-based compoundImmune System
Talk to your doctor
Questions to ask
- ·Is PX-478 part of a clinical trial I can join?
- ·What are the early-stage risks of PX-478?
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.